Seth Townsend is a seasoned executive with a track record of creating value through commercial turnarounds, due diligence for M&A, and restructuring to improve margin management.
Seth spent 5 years at McKinsey as part of the Healthcare practice, leading efforts across sales growth, pricing, operations, due diligence, M&A, and corporate strategy for companies in the pharmaceuticals, medical devices, and healthcare industry. Following his time at McKinsey, Seth worked at Novartis where he held roles in Commercial, Shared Services, Finance, and Operations in both the US and Switzerland. He was the Head of Commercial Support Operations in the Sandoz Division, a global leader in generics and biosimilars where he led a team of over 30 people across insights & analytics, salesforce effectiveness, sales training, and data services. Seth was the SVP Transformation for Beacon Health Options, the largest private behavioral health company with sales of over $2B (now part of Anthem). There, he led initiatives across transaction management, margin improvement / value creation, and organizational restructuring. Seth was most recently VP of Corporate Strategy at Thermo Fisher Scientific where he led cross-company initiatives, partnered with the company leadership team to build 5-year strategic plans, investor day, and BoD presentations, and led due diligence on over 50 targets to support M&A and integrations.
Seth holds a Global Executive MBA with distinction from INSEAD, a PhD in Biological Engineering from MIT, and a BS in Biomedical Engineering from Johns Hopkins University. Seth lives with his wife and two daughters in New York City. He would be excited to collaborate on projects in the pharmaceutical, healthcare, and private equity industries.
Umbrex independent consultants are available where you need them – in all major markets and every global region.